Predictors of Early Neurological Deterioration in Stroke Due to Vertebrobasilar Occlusion
Overview
Authors
Affiliations
This study explores the predictors of early neurological deterioration (END) in patients with vertebrobasilar occlusion (VBO) in both primary endovascular therapy (EVT) and medical management (MM) groups. Patients diagnosed with VBO from 2010 to 2018 were included. Comparative and multivariate analyses were used to identify predictors of all-cause END in the EVT group, and END due to ischemia progression (END-IP) in the MM group. In 174 patients with VBO, 43 had END. In the primary EVT group ( = 66), 17 all-cause END occurred. Distal basilar occlusion (odds ratio (OR), 14.5 [95% confidence interval (CI), 1.4-154.4]) and reperfusion failure (eTICI < 2b67 (OR, 5.0 [95% CI, 1.3-19.9]) were predictive of END in multivariable analysis. In the MM group (N=108), 17 END-IP occurred. Higher systolic blood pressure (SBP) at presentation (per 10 mmHg increase, OR, 1.5 [95% CI, 1.1-2.0]), stroke onset-to-door time <24 h (OR, 5.3 [95% CI, 1.1-2.0]), near-total occlusions (OR, 4.9 [95% CI, 1.2-19.6]), lower posterior circulation-Alberta Stroke Program Early CT scores (OR, 1.6 [95% CI, 1.0-2.5]), and lower BATMAN collateral scores (OR, 1.6 [95% CI, 1.1-2.2]) were predictive of END-IP. In patients with stroke due to VBO, potential predictors of END can be identified. In the primary EVT group, failure to achieve reperfusion and distal basilar occlusion were associated with all-cause END. In the MM group, higher SBP at presentation, onset-to-door time less than 24 h, incomplete occlusions, larger infarct cores, and poorer collaterals were associated with END-IP.
Lieschke F, Rauch M, Roller B, Schaefer J, Schaller-Paule M Neurocrit Care. 2025; .
PMID: 39920543 DOI: 10.1007/s12028-025-02219-y.
Endovascular Treatment of Basilar Artery Occlusion: What Can We Learn from the Results?.
Ekkert A, Jokimaityte U, Tutukova V, Lengvenis G, Masiliunas R, Jatuzis D Medicina (Kaunas). 2023; 59(1).
PMID: 36676720 PMC: 9866638. DOI: 10.3390/medicina59010096.
Endovascular Treatment for Posterior Circulation Stroke: Ways to Maximize Therapeutic Efficacy.
Lee S, Hong J, Kim J, Lee J J Stroke. 2022; 24(2):207-223.
PMID: 35677976 PMC: 9194547. DOI: 10.5853/jos.2022.00941.
Kim M, Park S, Lee S, Lee J, Hong J, Lee S Front Neurol. 2022; 13:845707.
PMID: 35651338 PMC: 9150563. DOI: 10.3389/fneur.2022.845707.